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Studies of the mechanism of epidemic respiratory diseases in a con- 
centrated infant population  1 previously reported  (1)  have indicated 
that  the etiology of these disorders may be a  complex one.  It has 
been noted that respiratory infection occurring in the autumn, when 
the carrier rate of pathogenic bacteria is low, usually takes the form 
of a  minor disturbance of the type of the common cold.  Later on, 
in the winter months, when a widespread dissemination of pathogenic 
bacteria takes place in certain groups of infants, an outbreak of infec- 
tions in these groups takes on a more serious character.  The majority 
of these infections present two features in common, fever and consti- 
tutional  reaction;  thus  they are no longer designated as  colds,  but 
rather as grippe, pharyngitis, otitls media, bronchitis, or pneumonia, 
depending on the region principally involved.  During the past few 
years it has been established that there exists in adults suffering from 
the common cold (2-5) a typical filtrable virus.  There is every reason 
to suppose that this virus is equally pathogenic for infants.  It has 
therefore been possible to construct an hypothesis as to the mechanism 
of development of epidemic respiratory diseases in infants:  the filtra- 
ble virus alone produces the mild autumnal disturbance, the common 
cold; later on, when the carrier rate of pathogenic organisms becomes' 
very high, it acts as an initiating agent which permits these bacteria 
to produce more severe infections. 
Because of the existence of this filtrable virus, it is illogical to sup- 
pose that vaccination of adults with the bacteria of the upper respira- 
I These  studies  were made  at  The Home for Hebrew  Infants in New  York 
City through the courtesy of the late Dr.  Alfred F.  Hess and other  members 
of the staff. 
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tory tract would prevent the common cold, and this has been amply 
established  by  most  of  the  well  controlled  experiments  along  this 
line  (6-9).  On  the  other  hand,  if  our  hypothesis  in  regard  to  the 
etiology of epidemic respiratory diseases in a  dense infant population 
be correct,  vaccination with  the  secondary invaders  should  diminish 
the  severity of the  febrile  and  complicated  forms of  these  diseases. 
A -study, therefore,~ was conducted with this in view. 
The only record that has been found of the use of such vaccines in early in- 
fancy is included in a report by Stoltenberg (10).  New admissions to a children's 
hospital in Oslo were treated with a bacterial vaccine, and of a group of 500 so 
treated during a  5 year period, approximately 50 were under  1 year of age.  A 
similar number of infants in the preceding 5 year period were considered as con- 
trols.  The frequency of febrile infections was given as roughly five times greater 
in the non-vaccinated group, and the number of complications also larger. 
Previous experience (1) had led us to the belief that pneumococcus, 
H.  influenzae,  and  hemolytic  streptococcus  are  the  most  important 
pathogenic bacteria of the upper respiratory tract in infancy.  It was 
therefore decided to employ a  vaccine composed only of these organ- 
isms, in the  hope that its simplicity would render it a  more effective 
antigen  than  the  average  "catarrhal"  vaccine. 
Methods 
Pneumococci were cultivated for 24 hours in beef infusion  broth.  The washed 
organisms were taken up in salt solution with 0.2 per cent phenol and heated to 
60°C.  for 30 minutes.  Because of the fact that a  considerable variety of types 
is recovered from infants--and it seemed  difficult  at the time to include  all  of 
these--it was thought  that  the most one could hope to produce was a non-type- 
specific active immunity.  Consequently, the Neufeld strain of Type I pneumo- 
coccus  was employed.  It has recently been shown,  however, by Goodner and 
Stillman  (11) that this non-type-specific immunity is low in rabbits when their 
resistance to dermal pneumococcus infection is quantitatively estimated. 
The  hemolytic streptococcus vaccine was similarly prepared,  except  that  it 
was heat-killed at 60°C. for 1 hour.  Four strains, supplied by Dr. M. H. Dawson, 
were employed, derived from scarlet fever, rheumatic fever, erysipelas, and rheuma- 
toid  arthritis  respectively.  Dr.  Margaret  Pittman  of  The  Rockefeller  Insti- 
tute kindly provided us with two smooth strains of H. influenzae, Types A and B. 
These organisms were cultivated 24 hours in clear chocolate broth, washed,  sus- 
pended in carbolized  saline,  and heated to 60°C. for 45 minutes. 
A group of twenty-three infants at the Home was designated as the one for 
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control.  The average age of each at the beginning of the observation period was 
6.4 months.  Starting in the latter part of October, 1932, a course of nine subcu- 
taneous injections of the vaccine was administered to the first group.  The initial 
dose of organisms  was 45 million, the final dose 750 million.  The proportion of 
pneumococcus  to  H.  infl~nzae  to  streptococcus in  each  mixture  was  5:3:3 
approximately.  Early in February a  second course of seven weekly  in~ections 
was administered to the treated group.  The initial dose in this course was  190 
million, the final dose 1000 million. 
Some local redness and induration were produced by the larger doses of vac- 
cine.  No febrile or constitutional reaction was ever observed.  It is to be noted 
that the administration of vaccine was always omitted if the infant had a febrile 
respiratory infection at the time; in this way, three members of the vaccinated 
group missed nearly all of the second course.  They were not excluded, however, 
on this account from the tabulation of the clinical history of the group. 
RESULTS 
The  two  groups  showed  no  significant  difference in  the  incidence 
of minor respiratory infection of the type of the  common cold. 
The  experience  of  each  group  in  regard  to  the  febrile  forms  of 
respiratory disease is graphically indicated in Chart  I.  In this chart 
is given the  total number of days of  temperature  over 100  °  due  to 
respiratory  disease  for  each  month  in  the  two  groups.  It  will  be 
observed that  there was very little febrile infection during October. 
In November, half way through the first course  of vaccine, the two 
groups  fared  almost  identically.  In  December,  also,  the  difference 
was  slight.  By  January,  however,  there  was  a  striking  difference 
between the vaccinated and the control, the latter showing three times 
as many days of fever as the former.  The peak of respiratory disease 
was  reached in February, and in this month--half way through the 
second course--it will be seen that the difference between the groups 
is less marked,  for the vaccinated infants showed more than half as 
many  febrile  days  as  the  controls.  There  is  a  falling  off for both 
groups in March, but it is to be observed that while this decline con- 
tinues in the vaccinated group during April,  it does not do so in the 
control.  In May,  both fell to their original low level. 
The actual number of individual respiratory infections of all types 
per child--5.4 in the vaccinated,  and 5.8 in the control--was almost 
the same in the two groups.  The difference in severity, however, is 
further illustrated by the incidence of pneumonia; there were five cases 658  VACCINATION  OF  INFANTS 
among the controls as opposed to two in the vaccinated, and of the 
latter one case occurred when the first course of vaccination was only 
half completed. 
In spite of the fact that the N. Y. 5  strain of scarlatinal strepto- 
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coccus was included in  the vaccine, two of the vaccinated children 
developed scarlet fever, as well as one control.  There was evidence, 
however, that  the causative  streptococcus of this  outbreak was an 
atypical one. 
DISCUSSION 
The data obtained in this experiment give evidence that vaccina- 
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modifies in  degree  the  subsequent respiratory  disease  which  these 
infants will undergo.  There is no alteration in the number of acute 
infections, and no change in  the  simple catarrhal  infections of the 
upper respiratory tract.  There is, however, a  significant alteration 
in the severity of respiratory infection, as measured by the number 
of days of fever that occur.  The age group selected for study was 
the one in which our experience indicated that the greatest incidence 
and severity of respiratory infection might be  expected during the 
winter months.  Even in this age group which, in institutions, invaria- 
bly  shows so  high a  susceptibility to  epidemic respiratory  disease, 
vaccination  with  common pathogens  is  effective  in  reducing  the 
severity of these epidemics.  The interest here lies  chiefly in  such 
light as is thrown on the mechanism of epidemic respiratory disease. 
Earlier in this report an hypothesis was put forth that the character 
of certain winter outbreaks of grippe, etc., is determined by the pres- 
ence of a widespread carrier state of ordinary pathogenic bacteria; the 
study herein described would seem to lend additional support to this 
hypothesis, inasmuch as vaccination with these pathogens has been 
found to modify significantly the severity of these outbreaks. 
Certain other features of these results are worthy of brief comment. 
A  study of the curve given in Chart  1 would seem to indicate that 
immunity in these infants did not manifest itself until a rather large 
amount of vaccine had been administered.  It would also appear that 
the  immunity finally  engendered did  not  last  much more  than  2 
months. 
With the increasing data now available as to the frequency of the 
various newly identified types of pneumococcus carried in infancy, it 
seems probable that more striking results would have been obtained 
by the use of a  vaccine containing these types instead of Type I. 
SUMMARY  AND  CONCLUSIONS 
An intensive  course of vaccination with the pathogenic bacteria of 
the upper respiratory tract  modified favorably the winter outbreak 
of severe respiratory  disease  in an infant population.  The incidence 
of the common cold was not affected. 
The significance  of these findings  is discussed. 660  VACCINATION OF IN]~ANTS 
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